MedTrace Logo

Invasive Markers of Staphylococcus Epidermidis

NCT03374371 · Status: COMPLETED · Type: OBSERVATIONAL · Enrollment: 320

Last updated 2026-01-15

No results posted yet for this study

Summary

The purpose of the study is to identify biomarkers allowing the distinction between invasive and non-invasive strains of Staphylococcus epidermidis. This distinction is important to determine if the patient is infected and, as a consequence, if an antibiotic treatment is required.

Conditions

  • Staphylococcus Epidermidis Positive Blood Culture

Interventions

DIAGNOSTIC_TEST

high-throughput sequencing

technique of high-throughput sequencing of the markers present in the genome of the S. epidermidis strains responsible for infection in order to help to discriminate the true infections of the contaminations

Sponsors & Collaborators

  • URC-CIC Paris Descartes Necker Cochin

    collaborator OTHER

  • Assistance Publique - Hôpitaux de Paris

    lead OTHER

Principal Investigators

  • Anne JAMET, MD · Assistance Public Hôpitaux de Paris (APHP)

Eligibility

Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2018-03-01
Primary Completion
2020-12-18
Completion
2020-12-18

Countries

  • France

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT03374371 on ClinicalTrials.gov